HBIO
HARVARD BIOSCIENCE INC
NASDAQ · Healthcare · Medical - Instruments & Supplies · US
$8.61
−0.69%Forward multiples
Based on analyst estimates
- P/E forward
- 13.25x
- P/E 2026E
- —
- P/E 2027E
- 13.33x
- P/E 2028E
- 20.00x
- P/S forward
- 0.42x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 5.28x
- Price / sales
- 0.45x
- Price / cash flow
- 60.39x
Enterprise value
- Enterprise value
- $76.9M
- EV / sales
- 0.88x
- EV / EBITDA
- -43.87x
- EV / EBIT
- 74.88x
- Market cap
- $39.2M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026